Background
Pharmacokinetic and pharmacodynamic profile
Rationale for evaluating topiramate in psychiatric disorders
Methods
Results
Condition | Number of studies | Design | Outcome |
---|---|---|---|
Bipolar disorders
| |||
Bipolar mania
| 8 | 5 controlled (*) | Negative |
3 open label (70–72) | Positive | ||
Rapid-cycling bipolar disorders
| 1 | Open label, add-on (75) | Positive |
Adjunctive therapy (refractory bipolar disorders)
| 12 | Open label (76–87) | Positive |
Bipolar depression
| 2 | 1 Controlled, add-on (88) | Positive |
1 Open label, add-on (89) | Positive | ||
Bipolar disorders in children and adolescents as adjunctive treatment
| 1 | Open label, add-on (90) | Positive |
Unipolar depression
| 2 | 1 Case report (91) | Negative |
1 Chart review (92) | Positive | ||
Schizophrenia, schizoaffective disorders and psychosis unspecified
| 3 | 2 Case series (93, 94) | Negative |
1 Case report (95) | Positive | ||
Eating disorders and disordered eating
| 4 | 2 Controlled (96, 97) | Positive |
1 Open label, add on (98) | Positive | ||
1 Case series, add on (99) | Positive | ||
Posttraumatic stress disorder
| 1 | Open label, add on (100) | Positive |
Alcohol dependence
| 1 | Controlled (101) | Positive |
Gilles de la Tourette's syndrome
| 1 | Case series (102) | Positive |
Emotional unstable personality disorder
| 1 | Case reports (103) | Positive |
Bipolar disorders
Bipolar mania
Rapid-cycling bipolar disorders
Adjunctive therapy in treatment-refractory bipolar disorders
Bipolar depression
Bipolar disorders in children and adolescents as adjunctive treatment
Unipolar depression
Schizophrenia, schizoaffective disorders and psychosis unspecified
Eating disorders and disordered eating
Posttraumatic stress disorder
Alcohol dependence
Gilles de la Tourette's syndrome
Emotional unstable personality disorder
Adverse events, safety and tolerability
Adverse events * | Topiramate (N = 896) N (%) |
---|---|
Paresthesia/numbness | 116 (12.9) |
Nausea/vomiting | 56 (6.2) |
Cognitive impairment | 48 (5.4) |
Headache | 46 (5.1) |
Dizziness | 45(5.0) |
Sedation/drowsiness | 44 (4.9) |
Fatigue | 38 (4.2) |
Decreased appetite | 24 (2.7) |
Frequent peristalsis | 20 (2.2) |
Somnolence | 19 (2.1) |
Blurred vision | 18 (2.0) |
Slow memory | 16 (1.8) |
Lack of concentration | 11 (1.2) |
Influenza-like-symptoms | 10 (1.1) |
Panic/anxiety | 9 (1.0) |
Dysgeusia | 8 (0.9) |
Dry mouth | 8 |
Nervousness | 7 (0.8) |
Rash | 7 |
Ataxia | 7 |
Insomnia | 7 |
Constipation | 7 |
Reduced libido | 5 (0.6) |
Memory concerns | 5 |
Dyspepsia | 5 |
Unwanted weight loss | 4 (0.4) |
Increased thirst | 4 |
Word-finding difficulty | 4 |
Impaired concentration | 4 |
Tremor | 4 |
Itching | 4 |
Sweating | 3 (0.3) |
Confusion | 3 |
Slowed thinking | 3 |
Psychosis | 3 |
Slurred speech | 3 |
Increased salivation | 3 |
Sleep disturbance | 3 |
Backache | 3 |
Increased appetite | 2 (0.2) |
Gastrointestinal disturbances | 2 |
Agitation | 2 |
Cold sensitivity | 2 |
Worsening of symptoms | 2 |
Increased libido | 2 |
Amenorrhea | 1 (0.1) |
Hematuria | 1 |
Dysuria | 1 |
Urticaria | 1 |
Increased suicidality | 1 |
Glaucoma | 1 |
Water retention | 1 |
Delirium | 1 |
Grand mal seizures | 1 |